![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nexgenrx Inc | TSXV:NXG | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.28 | 0.30 | 0.345 | 0 | 12:30:02 |
NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) is pleased to report financial results for its first quarter, ended March 31, 2013. Revenue from transaction fees for the quarter ended March 31, 2013 was $1,268,643 representing an increase of 15.4% over the prior year period. The gross profit for the period was $1,065,007, an increase of 26.6% compared to the same quarter in 2012. "The 2013 first quarter results reflect an increase in new client revenue and balance sheet improvement. We achieved positive net income of $262,375 representing an increase of over $200,000 in comparison to the same period in 2012. In addition, our available cash on hand of $520,666 represents an increase of over $500,000 in comparison to the same quarter in 2012. This additional cash will enable us to deploy the resources needed to accelerate our new sales strategy and continue our growth." stated Ron Loucks, President and CEO. About NexgenRx NexgenRx is a growing health benefits management company engaged in the design, management and administration of health benefit plans offered by employers and other plan sponsors for the benefit of their employees and plan members. More information on NexgenRx can be found at www.nexgenrx.com. Caution Regarding Forward-Looking Statements - This news release contains certain forward looking statements, including statements regarding the business and anticipated financial performance of the Corporation. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements. FOR FURTHER INFORMATION PLEASE CONTACT: NexgenRx Inc. Ronald C. Loucks President and CEO 416.695.3393 x801 NexgenRx Inc. Taba Merrikh Director of Finance 416-695-3393x803 www.nexgenrx.com
1 Year Nexgenrx Chart |
1 Month Nexgenrx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions